J-mab Therapeutics
J-mab Therapeutics is dedicated to the development of anti-Hodgkin lymphoma drugs.
J-mab Therapeutics is a company in biotechnology, pharmaceutical, therapeutics based in Asia-Pacific (APAC), founded in 2017.
The company sits in the biotechnology, pharmaceutical, therapeutics segment, where it competes on its core product or service.
The company is recorded as being based in Asia-Pacific (APAC).
The company is listed at the Private company stage of development.
| Sector | Biotechnology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2017 |
| Stage | Private company |
Website: www.j-mab.co.jp
Sign in to view the contact information we hold for J-mab Therapeutics.
Create a free account
Create a free account